# Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery

> **NCT03519165** · NA · COMPLETED · sponsor: **Tata Medical Center** · enrollment: 145 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DEVICE:** EV1000(FloTrac System 4.0)

## Key facts

- **NCT ID:** NCT03519165
- **Lead sponsor:** Tata Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2019-06
- **Final completion:** 2019-09
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2020-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03519165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03519165, "Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03519165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*